Find a Commonwealth Resource
Patent AT-E400289-T1: [Translated] USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR 2 (VEGF-2)
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The present invention is directed to VEGF-2 antibodies and methods of using such antibodies. In particular, provided are methods of inhibiting proliferation of photoreceptor cells with VEGF-2 antibodies.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E400289-T1: [Translated] USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR 2 (VEGF-2) on the official website.
Modified Aug 13, 2026